A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2009
11/25/2009	EP1963318B1 Pyrrolo[2,3-c]pyridine derivatives
11/25/2009	EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009	EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009	EP1210108B1 Use of leptin together with an inhibitor of vegf and/or an inhibitor of angiogenesis for the inhibition of endothelial cell proliferation
11/25/2009	EP1144405B1 Triazole compounds with dopamine-d3-receptor affinity
11/25/2009	CN101589062A Compositions and methods relating to glucagon receptor antibodies
11/25/2009	CN101589041A Nitrogen-containing heterocyclic compounds and methods of use thereof
11/25/2009	CN101589039A Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
11/25/2009	CN101589037A Heteromonocyclic compound and use thereof
11/25/2009	CN101588843A Assay
11/25/2009	CN101586103A RNA interference sequence of glucagon receptor gene
11/25/2009	CN101585887A Method for desalting and concentrating dextriferron complex compound aqueous solution by nanofiltration technology
11/25/2009	CN101585885A Method for preparing polygonatum odoratum polysaccharide
11/25/2009	CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009	CN101585863A Method for preparing yamogenin
11/25/2009	CN101585858A Application of glycosylated puerarin derivate and its combination for preventing and treating cardiovascular and cerebrovascular disease
11/25/2009	CN101585757A Method for preparing curcumin, demethoxycurcumin and bisdemethoxycurcumin
11/25/2009	CN101584844A Compound Chinese traditional medicine identification method
11/25/2009	CN101584842A Medicament for treating coronary disease, angina pectoris and reducing blood fat, blood sugar, and preparation method thereof
11/25/2009	CN101584793A Pure natural health-care four-Huai medicine
11/25/2009	CN101584776A Cordyceps P.E. nutrition capsule
11/25/2009	CN101584772A Traditional Chinese medicine for treating diabetes surrounding nerve lesion
11/25/2009	CN101584757A Traditional Chinese medicine composition for treating diabetic nephropathy
11/25/2009	CN101584739A Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes
11/25/2009	CN101584738A Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes
11/25/2009	CN101584737A Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes
11/25/2009	CN101584736A Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes
11/25/2009	CN101584733A Pharmaceutical composition used for reducing blood fat
11/25/2009	CN101584732A Pharmaceutical composition used for reducing blood fat
11/25/2009	CN101584731A Pharmaceutical composition used for reducing blood fat
11/25/2009	CN101584729A Pharmaceutical composition used for reducing blood fat
11/25/2009	CN101584728A Pharmaceutical composition used for reducing blood fat
11/25/2009	CN101584727A Pharmaceutical composition used for reducing blood fat
11/25/2009	CN101584726A Pharmaceutical composition used for reducing blood fat
11/25/2009	CN101584725A Pharmaceutical composition used for reducing blood fat
11/25/2009	CN101584724A Pharmaceutical composition used for reducing blood fat
11/25/2009	CN101584719A Application of acanthopanax fruit extractive in preparing medicament for treating hyperlipoidemia
11/25/2009	CN101584716A Red yeast rice extract oil and the preparation and application of the soft capsule thereof
11/25/2009	CN101584712A Composite preparation composed of nervonic acid, composite mineral matter and composite vitamin
11/25/2009	CN101584710A Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes
11/25/2009	CN101584709A Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes
11/25/2009	CN101584708A Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes
11/25/2009	CN101584707A Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes
11/25/2009	CN101584706A Pharmaceutical composition used for reducing blood sugar and blood fat and treating diabetes
11/25/2009	CN101584705A Medicament composition for treating diabetes and complications of diabetes
11/25/2009	CN101584704A Medicinal application of medicinal salt or derivative of heparin and low molecular heparin
11/25/2009	CN101584700A Pharmaceutical composition
11/25/2009	CN101584699A Application of lactoflavin ester derivative for preparing medicine for treating diabetes mellitus and complication thereof
11/25/2009	CN101584691A Compounds effecting glucokinase
11/25/2009	CN101584688A Medicament composition for treating diabetes and complications of diabetes
11/25/2009	CN101584687A Application of alfa-ketoglutaric acid iron in preparing iron-filling drug and health care product
11/25/2009	CN101584685A Medicine composition for regulating blood fat
11/25/2009	CN101584682A Rutin-arabic-gum-gelatin slowreleasing microspheres and preparation thereof
11/25/2009	CN101584460A Spleen invigorating and blood-glucose decreasing health-protection tea for middle and old aged people to drink
11/25/2009	CN101584371A Health-care tea for nourishing yin, clearing away heat and reducing blood glucose for middle-old aged people
11/25/2009	CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009	CN100562514C Substituted propion amide derivatives, their preparing method and use
11/25/2009	CN100562315C Active compound of Baojiwan pill for resisting diarrhea and reducing gastrointestinal illness
11/25/2009	CN100562314C Use of phthalide derivatives for the treatment and prevention of diabetes mellitus
11/25/2009	CN100562313C Combined use of a fibrate and orlistat for the treatment of obesity
11/25/2009	CN100562255C Quick-frozen fresh forage used for special aquatic product and production process therefor
11/24/2009	US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009	US7622449 4-[(2S,3R)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-1-(4-{3-[(methylsulfonyl)amino]propyl}phenyl)-4-oxoazetidin-2-yl]phenyl methyl beta -D-glucopyranosiduronate; useful for lowering plasma cholesterol levels, particularly low density lipoprotein, treating and preventing atherosclerosis
11/24/2009	US7622447 Use of glutathione synthesis stimulating compounds in reducing insulin resistance
11/24/2009	US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/24/2009	CA2526145C C-glycoside derivatives or salts thereof for use as na+-glucose cotransporter inhibitors
11/24/2009	CA2520955C A process for preparation of hypoglycemic foods and formulations thereof
11/24/2009	CA2480668C Compositions comprising dietary fat complexer and methods for their use
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2448030C Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester
11/24/2009	CA2445678C Paroxetine controlled release compositions
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009	CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2377330C Combination therapy for effecting weight loss and treating obesity
11/24/2009	CA2192592C Cross-linked polymers for removing bile salts from a patient
11/19/2009	WO2009140624A2 Glucokinase activators
11/19/2009	WO2009139822A1 Anti-hepcidin antibodies and methods of use
11/19/2009	WO2009139634A1 Radiolabelled mmp selective compounds
11/19/2009	WO2009139633A1 Radiolabelled mmp selective compounds
11/19/2009	WO2009139506A1 Combination of drugs having different physical properties into single dosage form
11/19/2009	WO2009139470A1 Pharmaceutical composition for treatment of fibromyalgia
11/19/2009	WO2009139459A1 Method for prevention and treatment of metabolic syndrome through the inhibition of psgl-1
11/19/2009	WO2009139362A1 Pharmaceutical preparation comprising dpp-iv inhibitor and other diabetes therapeutic agent in concomitant or combined form
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009	WO2009139340A1 Pyrazole compound
11/19/2009	WO2009139298A1 Metastin derivative and use thereof
11/19/2009	WO2009139167A1 Nutrient composition capable of adjusting energy amount, water amount and salt equivalent
11/19/2009	WO2009139076A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/19/2009	WO2009138762A2 Therapeutic use of peptides
11/19/2009	WO2009138437A1 Salicylate conjugates useful for treating metabolic disorders
11/19/2009	WO2009138035A1 Screening method for medicine of blocking cholesterol absorption based on analyzing subcellular localization of npc1l1 protein
11/19/2009	WO2009137966A1 A inhibitor for depressing the absorption of sucrose
11/19/2009	WO2009137880A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
11/19/2009	WO2009137879A1 Orally administrable dosage forms comprising angiogenin and uses thereof
11/19/2009	WO2009137859A1 Compounds for the treatment of metabolic syndrome and insulin resistance
11/19/2009	WO2009118473A3 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
11/19/2009	WO2009105218A3 Propiophenone derivatives
11/19/2009	WO2009074300A8 Hedgehog pathway antagonists and therapeutic applications thereof
11/19/2009	WO2009046220A3 Lipopeptides for delivery of nucleic acids

1 ... 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 ... 1298